Tamar D Howson Receives Stock Award at MEI Pharma Inc (MEIP) — SEC Form 4, Jul 07, 2022

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Tamar D Howson

Director

TXN 2022-07-05 · FILED 2022-07-07

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

MEI Pharma Inc

MEIP CIK 0001262104

Reporting Owner

Name	Relationship
Tamar D Howson CIK 0001202286	Director

Tamar D Howson at MEI Pharma Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at MEI Pharma Inc

2023-10-12	Award	—	View
2021-07-06	Award	—	View

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (Right to Buy)F1	$0.54	2022-07-05	A - Award/Grant	87,500 A	$0.00	2032-07-05	87,500 Common Stock	Direct

Derivative Holdings

Title	Amount	Exercise Price	Expiration
Stock Option (Right to Buy)F3 Common Stock	50,000	$2.95	2031-07-01
Stock Option (Right to Buy)F2 Common Stock	60,000	$2.52	2029-07-01
Stock Option (Right to Buy)F3 Common Stock	50,000	$3.49	2030-07-02

Footnotes (3)

F1: The options will vest in equal monthly installments over twelve months. Show more
F2: 40,000 of the options vested on July 1, 2020, and are currently exercisable and 20,000 options will vest in equal monthly installments over thirty-six months beginning July 1, 2019. Show more
F3: All of such options are presently exercisable. Show more

5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at MEI Pharma Inc

GET /v1/forms/4/0000899243-22-025710 API docs